fingolimod hydrochloride has been researched along with Focal Segmental Glomerulosclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawachi, H; Krämer, S; Martini, S; Neumayer, HH; Peters, H; Shimizu, F; Wang, Y | 1 |
| Hao, Y; Xie, M; Zhou, JH; Zhu, GQ | 1 |
2 other study(ies) available for fingolimod hydrochloride and Focal Segmental Glomerulosclerosis
| Article | Year |
|---|---|
Selective lymphocyte inhibition by FTY720 slows the progressive course of chronic anti-thy 1 glomerulosclerosis.
Topics: Animals; Blood Pressure; Blood Urea Nitrogen; Body Weight; Creatinine; Extracellular Matrix; Fibrosis; Fingolimod Hydrochloride; Glomerulosclerosis, Focal Segmental; Heart Rate; Immunosuppressive Agents; Isoantibodies; Lymphocyte Count; Lymphocytes; Male; Propylene Glycols; Proteinuria; Rats; Rats, Wistar; Sphingosine | 2004 |
[Effect of FTY720 on glomerulosclerosis and expression of cell cycle regulatory proteins in subtotally nephrectomized rats].
Topics: Animals; Cell Cycle Proteins; Disease Models, Animal; Fingolimod Hydrochloride; Glomerulosclerosis, Focal Segmental; Immunosuppressive Agents; Kidney; Male; Nephrectomy; Postoperative Period; Propylene Glycols; Rats; Rats, Sprague-Dawley; Sphingosine | 2007 |